Davenport & CO LLC Catalent, Inc. Transaction History

Davenport & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$87.2 - $114.05 $52,058 - $68,087	-597 Reduced 21.43%	2,189 $235,000
Q1 2022 May 02, 2022	BUY	$94.19 - $124.49 $15,918 - $21,038	169 Added 6.46%	2,786 $309,000
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $54,165 - $62,998	453 Added 20.93%	2,617 $335,000
Q3 2021 Oct 14, 2021	BUY	$109.17 - $142.35 $26,528 - $34,591	243 Added 12.65%	2,164 $288,000
Q2 2021 Jul 28, 2021	BUY	$100.34 - $115.69 $192,753 - $222,240	1,921 New	1,921 $208,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.